Study finds long-acting shot helps women avoid HIV infection


The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

©2021 GPlusMedia Inc.

Login to comment

Cost of a shot compare to pills ?

And it is not a scientific study. It is a practical study only.

If it just limit spreading over time, it is just leaving more time to live but not avoid catching it in the long term...

-1 ( +1 / -2 )

And it is not a scientific study. It is a practical study only.

That makes no sense, methods is what make a study scientific or not, a practical application is irrelevant for this, the trial is HPTN 084, a "phase 3 double blind safety and efficacy study of long-acting injectable Cabotegravir compared to daily roal TDF/FTC for pre-exposure prophylaxis in HIV-uninfected women."

This would mean is a scientific study no matter how you want to define it.

And no, what is spreading over time is the dosing, the effect is the same, preventing infection. The inyectable version is not yet priced but the Truvada pills are about $2,000 a month, so it is quite easy to make it cost effective, especially taking in account adherence to the method which is a problem for all daily oral formulations. It is also easier to include in medical insurance plans because it can be controlled more closely and is less susceptible to be abused.

1 ( +2 / -1 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites